An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection

Leukemia Research

Volumn 23, Issue 10, 1999, Pages 921-929

  Galimberti, Sara ^a   Brizzi, Francesca ^a   Mameli, Marina ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

GeneScan analysis; IgH rearrangement; Minimal residual disease

Indexed keywords

IMMUNOGLOBULIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN STRUCTURE; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION;

EID: 0032843056     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00110-1     Document Type: Article

References (30)

1. Brisco J., Hughes E., Neoh S.H., Sykes P.J., Bradstock K., Enno A. et al. Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood. 87:1996;5251.
2. Zhang W., Zhu P., Yu S. Detection of minimal disease in bone marrow from non-Hodgkin's lymphoma and its clinical significance. Chung Hua I Hsueh Tsa Chih. 76:1996;207.
3. Korsmeyer S.J. Antigen receptor genes as molecular markers of lymphoid neoplasms. J. Clin. Invest. 79:1987;1291.
4. Saiki R.K., Scharf S., Fallona F., Mullis K.B., Horn G.T., Erlich H.A. et al. Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1985;1350.
5. Chim J.C.S., Coyle L.A., Yaxley J.C., Cole-Sinclair M.F., Cannel P.K., Hoffbrand V.A. et al. The use of IgH fingerprint and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. Br. J. Haematol. 92:1996;104.
6. Gribben J.G., Neuberg D., Freedman A.S., Gimmi C.D., Pesek K.W., Barber M. et al. Detection by polymerase chain reaction of residual cells with the BCL2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood. 81:1993;3449.
7. Rimokh R., Berger F., Delson G., Digonnet I., Rouault J.P., Tigaud J.D. et al. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood. 83:1994;1871.
8. Hardingham J.E., Kotasek D., Sage R.E., Gooley L.T., Mi J.X., Dobrovic A. et al. Significance of molecular marker-positive cells after autologous peripheral-blood stem cell transplantation for non-Hodgkin's lymphoma. J. Clin. Oncol. 13:1995;1073.
9. Seriu T., Yokota S., Nakao M., Misawa S., Takaue Y., Koizumi S. et al. Prospective monitoring of minimal residual disease during course of chemotherapy in patients with acute lymphoblastic leukemia and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia. 9:1995;615.
10. Zwicky C.S., Maddocks A.B., Andersen N., Gribben J.G. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood. 88:1996;3314.
11. Von Neuhoff N., Dreger P., Suttorp M., Marget M., Kell S., Schmitz N. Comparison of different strategies of molecular genetic monitoring following autologous stem cell translantation in patients with follicular lymphoma. Bone Marrow Transpl. 22:1998;161.
12. Ritter J.H., Wick M.R., Adesokan P.N., Fitzgibbon J.F., Zhu X., Humphrey P.A. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am. J. Clin. Pat. 108:1997;60.
13. Reed T.J., Reid A., Wallberg K., O'Leary T.J., Frizzera G. Determination of B-cell clonality in paraffin-embedded lymphnodes the using the polymerase chain reaction. Diagn. Mol. Pathol. 2:1993;42.
14. De Re V., De Vita S., Carbone A., Ferraccioli G., Gloghini A., Marzotto A. et al. The relevance of VDJ PCR protocols in detecting B-cell clonal expansion in lymphomas and other lymphoproliferative disorders. Tumori. 81:1995;405.
15. Gribben J.C., Freedman A.S., Woo S.D., Blake K., Shu R.S., Freeman G. et al. All advanced stage Non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of BCL2 have residual containing the BCL2 rearrangement at evaluation and after treatment. Blood. 12:1991;3275.
16. Smith R.N. Accurate size comparison of short tandem repeat alleles amplified by PCR. Biotechniques. 18:1995;122.
17. Evans P.A., Short M.A., Owen R.G., Jack A.S., Forsyth P.D., Shiach C.R. et al. Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 16:1998;3616.
18. Linke B., Bolz I., Fayyazi A., von Hofen M., Pott C., Bertram J. et al. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes. Leukemia. 11:1997;10.
19. Potter M.N., Steward C.G., Maitland N.J., Oakhill A. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction. Leukeamia. 6:1992;289.
20. Cole-Sinclar M., Foroni L., Wright F., Mehta A., Prentice H.G., Hoffbrand A.V. Minimal residual disease in acute lymphoblastic leukaemia -PCR analysis of immunoglobulin gene rearrangements. Leuk. Lymphoma. 11:1993;49.
21. Rosenquist R., Lindstrom A., Li A.H., Roos G., Lindh J., Holmberg D. Low rate of somatic hypermutations characterize progressive B-cell lymphomas. Eur. J. Haematol. 61:1998;164.
22. Cleary J.M., Galili N., Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphoma. J. Exp. Med. 164:1986;315.
23. Kadowaki N., Hayashi T., Amakawa R., Akasaka T., Yabumoto K., Ohno H. et al. Class switch recombination of the immunoglobulin heavy chain gene frequently occurs in B-cell lymphomas associated with rearrangement of the BCL2 gene. Int. J. Hematol. 61:1995;69.
24. Heigth S.E., Swansbury G.J., Matutes E., Treleaven J.C., Catovsky D., Dyer M.J.S. Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia. Blood. 87:1996;5242.
25. Hallek M., Bergsagel P.L., Anderson K.C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 91:1998;3.
26. McCann J.C., Kanteti R., Shilepsky B., Miller K.B., Sweet M., Schenkein D.P. High degree of occult tumor contamination in bone marrow and peripheral blood stem cells of patients undergoing autologous transplantation for non-Hodgkin's lymphoma. Biol. Blood Marrow Transplant. 2:1996;37.
27. Wassrman R., Yamada M., Ito Y., Finger L.R., Reichard B.A., Shane S., Lange B., Rovera G. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood. 79:1992;223.
28. Ottensmeier C.H., Thompsett A.R., Zhu D., Wilkins B.S., Sweetenham J.W., Stevenson F.K. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood. 11:1998;4292.
29. Corradini P., Voena C., Astolfi M., Ladetto M., Tarella C., Boccadoro M. et al. High-dose sequential chemotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cells harvests and after autografting. Blood. 85:1995;1596.
30. Owen R.G., Jhonson R.J., Rawstrom A.C., Evans P.A., Jack A., Smith G.M. et al. Assessment of IgH PCR strategies in multiple myeloma. J. Clin. Pathol. 49:1996;672.